C44.89
C44.89: Other specified malignant neoplasm of overlapping sites of skin
Billable / specific codeICD-10-CM
C44.89 is a billable, specific ICD-10-CM code for other specified malignant neoplasm of overlapping sites of skin. It is valid for submission on a claim.
Check C44.89 with the rest of the claim: free scrubberExcludes1 inherited from the categories above C44.89
A category’s note binds every code beneath it.
Other codes that can never be billed with C44.89
Their own Excludes1 notes name this code, so the conflict is not listed above.
- C76Malignant neoplasm of other and ill-defined sites
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
C44.89 is named in 62 Medicare coverage policies: 62 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A53883Billing and Coding: Mohs Micrographic Surgery (MMS)
Code history
Unchanged in every release from FY2024 to FY2027.